Patricia L. Allen, VP of Finance/Treasurer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 13,810 shares at $32.05 ($440K) on 2007-10-25, disclosed to the SEC on 2007-10-26.
Scheduled sale ($440k) by VP of Finance/Treasurer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.54 | 100 | $3K | 0.7% |
| 2 | $31.60 | 100 | $3K | 0.7% |
| 3 | $31.61 | 200 | $6K | 1.4% |
| 4 | $31.64 | 100 | $3K | 0.7% |
| 5 | $31.67 | 200 | $6K | 1.4% |
| 6 | $31.69 | 700 |
| $22K |
| 5.0% |
| 7 | $31.70 | 1,200 | $38K | 8.6% |
| 8 | $31.72 | 100 | $3K | 0.7% |
| 9 | $31.73 | 100 | $3K | 0.7% |
| 10 | $31.74 | 400 | $13K | 2.9% |
| 11 | $31.78 | 700 | $22K | 5.1% |
| 12 | $31.84 | 100 | $3K | 0.7% |
| 13 | $31.85 | 100 | $3K | 0.7% |
| 14 | $31.86 | 528 | $17K | 3.8% |
| 15 | $31.87 | 787 | $25K | 5.7% |
| 16 | $31.88 | 1,900 | $61K | 13.8% |
| 17 | $31.89 | 1,900 | $61K | 13.8% |
| 18 | $31.92 | 200 | $6K | 1.5% |
| 19 | $31.93 | 1,800 | $57K | 13.1% |
| 20 | $31.94 | 100 | $3K | 0.7% |
| 21 | $31.96 | 100 | $3K | 0.7% |
| 22 | $31.97 | 600 | $19K | 4.4% |
| 23 | $31.98 | 300 | $10K | 2.2% |
| 24 | $31.99 | 200 | $6K | 1.5% |
| 25 | $32.01 | 100 | $3K | 0.7% |
| 26 | $32.02 | 200 | $6K | 1.5% |
| 27 | $32.03 | 100 | $3K | 0.7% |
| 28 | $32.04 | 500 | $16K | 3.6% |
| 29 | $32.05 | 395 | $13K | 2.9% |
| Total | $31.86 avg | 13,810 | $440K | 100% |
| Filing → |
| DCPH | SELL | 2020-01-28 | $3.3M | — | Filing → |
| ZFGN | BUY | 2016-07-26 | $50K | — | Filing → |
| ALNY | SELL | 2009-04-24 | $441K | — | Filing → |